Top Markets
#1 0G 0G +11.60%
#2 Cash Cat Cash Cat +10.66%
#3 Siacoin Siacoin +9.25%
#4 Arbitrum Arbitrum +7.02%
#5 Asteroid Shiba Asteroid Shiba +6.90%
#6 MarsCoin MarsCoin +6.72%
#7 Seeker Seeker +6.12%
#8 Metis Metis +6.04%
#9 Useless Coin Useless Coin +5.01%
#10 Story Story +4.27%
Coin of the day
0G 0G
設定
言語
日本
通貨
USD
テーマ
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
株式のランク #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
株価
$0.88012714
最終同期: 2026-08-31
時価総額
$439.58M
変化（1日）
-4.01%
変化（1年）
1,131.97%
国
FR
取引 Valerio Therapeutics S.A. (ALVIO)

カテゴリー

Healthcare
Valerio Therapeutics S.A.（ALVIO）の配当履歴
Valerio Therapeutics S.A.（証券コード：ALVIO）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのValerio Therapeutics S.A.（ALVIO）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH